Apheresis Market to Hit $4.41 Billion by 2031 as Disease Burden Lifts Demand
Updated
Updated · PR Newswire · Jun 5
Apheresis Market to Hit $4.41 Billion by 2031 as Disease Burden Lifts Demand
1 articles · Updated · PR Newswire · Jun 5
Summary
$4.41 billion is the projected size of the global Apheresis market in 2031, up from $3.02 billion in 2026, implying a 7.9% annual growth rate.
Rising autoimmune and neurological disease cases, more surgeries and trauma care, and broader healthcare access are driving demand for therapeutic apheresis, blood components and plasma collection.
Donor apheresis is forecast to post the fastest growth at a 58.2% CAGR, while Plasmapheresis is also set to expand quickly on demand for plasma-based therapies such as immunoglobulin and albumin.
Apheresis disposables held an 83.4% share in 2025, and centrifugation accounted for 79.8% as hospitals, blood banks and plasma centers favored its accuracy and high-volume processing.
North America is expected to remain the largest regional market, while Asia-Pacific is projected to grow fastest as China, India and other emerging economies expand healthcare infrastructure and blood-donation awareness.